Temporal trends and clinical characteristics of spontaneous intracerebral haemorrhage in the Waikato region of New Zealand: A hospital-based analysis

New Zealand Medical Journal

Volumn 124, Issue 1345, 2011, Pages 16-25

  Irwin, James ^a   Wright, Peter ^a   Reeve, Paul ^a  

^a WAIKATO HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CORRELATION ANALYSIS; ELECTRONIC MEDICAL RECORD; ETHNICITY; FEMALE; HOSPITAL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROIMAGING; NEW ZEALAND; RETROSPECTIVE STUDY; REVIEW; SURVIVAL; TREND STUDY;

AGE FACTORS; AGED; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; DIAGNOSTIC IMAGING; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW ZEALAND; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; WARFARIN;

EID: 80855163668     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010;9:167-76.
2. Sacco S, Marini C, Toni D, et al; Incidence and 10 year survival of intracerebral haemorrhage in a population based registry. Stroke 2009;40:394-9.
3. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral haemorrhage. N Engl J Med 2001;344:1450-60.
4. Anderson CS, Chakera TM, Stewart-Wynne EG, et al; Spectrum of primary intracerebral haemorrhage in Perth, Western Australia 1989-90: incidence and outcome. J Neurol Neurosurg Psychiatry 1994;57(8):936-40.
5. Islam MS, Anderson CS, Hankey GJ, et al. Trends in incidence and outcome of stroke in Perth, Western Australia during 1989 to 2001: the Perth community stroke study. Stroke 2008;39:776-82.
6. Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population based study. Lancet Neurol 2007;6:487-93.
7. Benatru I, Rouaud O, Durier J, et al. Stable stroke incidence rates but improved case fatality in Dijon, France, from 1985 to 2004. Stroke 2006;37:1674-9.
8. Sivenius J, Tuomilehto J, Immonen-Raiha P, et al. Continuous 15 year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke;2004:35:420-5.
9. World Health Organization http://apps.who.int/classifications/apps/icd/icd10online
10. R Development Core Team (2008). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org
11. Statistics New Zealand http://www.stats.govt.nz
12. Anderson CS, Carter KN, Hackett ML, et al. Trends in Stroke Incidence in Auckland, New Zealand, During 1981 to 2003. Stroke 2005;36;2087-93.
13. Hart RG, Benavente O, McBride R, et al. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis. Ann Intern Med 1999;131:492-501.
14. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study; Final results. Circulation 1991;84:527-39.
15. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-91.
16. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993;342:1255-62.
17. Iso H, Jacobs DR, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989;320:904-10.
18. SPARCL investigators. High Dose Atorvastatin after Stroke or Transient Ischaemic Attack. N Engl J Med 2006;355:549-59.
19. He J, Whelton PK, Vu B, et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998;280(22):1930-5.
20. Pharmac NZ. http://www.pharmac.govt.nz
21. Feigin V, Carter KM, Hackett ML, et al. Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002-2003. Lancet Neurol 2006;5:130-9.
22. Jiang B, Wang WZ, Chen H et al. Incidence and trends of stroke and its subtypes in China: Results from three large cities. Stroke 2006;37:63-5.
23. Ellison-Loschmann L, Pearce N. Improving Access to Health Care Among New Zealand's Maori Population. Am J Public Health. 2006 April; 96(4):612-7.
24. Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32:891-7.
25. Flaherty ML, Tao H, Haverbusch M, et al. Warfarin use leads to larger intracerebral hematomas. Neurology 2008;71:1084-9.
26. Zubkov A, Claassen DO, Rabinstein AA. Warfarin associated intraventricular hemorrhage. Neurol Res. 2007 Oct;29(7):661-3.
27. Rosenow F, Hojer C, Meyer-Lohmann C, et al. Spontaneous Intracerebral Haemorrhage. Prognostic factors in 896 cases. Acta Neurol Scand 1997;96:174-82.
28. Rosand J, Eckman MH, Knudsen KA, et al; The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004;164(8):880-4.